Archives: Agenda

ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice

Roundtable 1: Meeting Sustainability Targets for Pharma Supply Chains

Kamal Amin, Head of Clinical Supplies Management, Galderma

Roundtable 2: Managing Supply Chain Vendors to Ensure Smooth Logistical Operations

Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

Roundtable 3: Re-Engineering Clinical Trial Supply Chains: Building Faster, Smarter and More Resilient Global Operations

Chiara Venuti, Member of the Management Board, Cool Chain Association

Roundtable 4: Navigating CDMO Partnerships as a Small Biotech: Challenges and Practical Solutions

Amanda Brown, Clinical Trial Supply Manager, Immutep

 

Getting started with Sustainability – Gathering data, simulating and prioritizing

Sustainability has been one of the main goals of Pharma Companies in the past decade. But it can also be a daunting initiative, with many challenges to get it kicked-off. In this session, we will discuss:

  • BI’s vision and planning for CTS sustainability
  • Challenges of starting a sustainability initiative: gathering CO2 data, measuring, and improving
  • Simulating CO2 emissions and designing a trial for sustainability VS offsetting
  • Illustration through a business case

Optimising Clinical Trial Supply at Project Start-Up

 

How early involvement of clinical supply experts can de-risk trial start-up, streamline operations, and set studies up for long-term success.

 

 

  • Embedding supply chain expertise from protocol design through trial start-up
  • Critical early-stage decisions: site selection, vendor strategy, and outsourcing models
  • Packaging and labelling considerations to support speed, compliance, and flexibility
  • Forecasting methodologies to avoid shortages, waste, and rework
  • Key stakeholders and partners to engage during trial start-up (including N-side and service providers)

 

Elena Velasco, Clinical Supply Chain Specialist, mAbxience

Digging for Gold in IRT Data

  • Mining the rich operational data that flows through an interactive response system (IRT)
  • Gaining insights on supply planning, temperature management, and more in the IRT treasure-trove
  • Extracting significant value and ROI from clinical supplies optimization

Beyond the Buzzword: Patient Centricity in Clinical Trial Supplies

  • Patient Centricity in CTS: are we doing enough?
  • Partnering With Patient Experts: Bringing Lived Experience Into Packaging & Labelling
  • Patient Feedback and e-Labelling Lessons Learned
  • Designing for Inclusion: Making Labels & IFUs Accessible for Patients With Learning Disabilities

The case for unifying Supply Forecasting and RTSM

Clinical supply forecasting and RTSM systems have traditionally operated as separate entities. This session examines the compelling case for unifying these systems and the benefits that can accrue. Is this the future of clinical supply management? What does this imply for your studies.

In this session we will look at:

  • Operational challenges encountered in forecasting and RTSM systems seen as discrete solutions
  • Common integration models and why they fall short
  • The unified solution and its closed-loop capabilities
  • Business benefits including efficiency; cost savings and risk reduction

Join us to explore how this unification can transform clinical supply management from a reactive, manual process into a proactive, data-driven capability that reduces costs and risk and optimises clinical supply.